The association between insulin regimen and the risk of severe hypoglycemia and mortality in adults with type 2 diabetes. A large population based retrospective cohort study.
Reid H Whitlock, Zach Raizman, David Collister, Katherine J Bernier, Sarah M Sigurdson, Navdeep Tangri, Clara Bohm, Claudio Rigatto, Paul Komenda, Jennifer M Yamamoto
{"title":"The association between insulin regimen and the risk of severe hypoglycemia and mortality in adults with type 2 diabetes. A large population based retrospective cohort study.","authors":"Reid H Whitlock, Zach Raizman, David Collister, Katherine J Bernier, Sarah M Sigurdson, Navdeep Tangri, Clara Bohm, Claudio Rigatto, Paul Komenda, Jennifer M Yamamoto","doi":"10.1016/j.jcjd.2025.05.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To compare severe hypoglycemia and all-cause mortality between insulin regimens in people with type 2 diabetes on insulin.</p><p><strong>Methods: </strong>This retrospective cohort study included individuals with type 2 diabetes who received a first insulin prescription from Apr2007-Dec2018 in Manitoba, Canada. We used cox proportional hazard regression models to compare risks and time-to-events for severe hypoglycemia and all-cause mortality amongst insulin regimens, adjusting for covariates.</p><p><strong>Results: </strong>21,512 individuals were included with 1,156 (5.4%) individuals experiencing a severe hypoglycemic episode and 3,562 (16.6%) dying during the study period. When compared to long-acting insulin alone, short-acting, intermediate- plus short-acting, long- plus short-acting, and premixed insulins were associated with severe hypoglycemia. However, after removing individuals who had never been prescribed a non-insulin antihyperglycemic medication, short-acting was no longer associated with severe hypoglycemia with the adjusted HR going from 1.99(95% CI 1.44-2.74) for the entire cohort to 1.13(95% CI 0.63-2.04). When compared to long-acting insulin, short-acting insulin alone and premixed insulin were associated with a higher all-cause mortality in both the main analysis (adjusted HR 2.36[95% CI 2.06-2.72] and 1.17[95% CI 1.04-1.31], respectively) and the analysis which removed individuals who had never been prescribed a non-insulin antihyperglycemic agent.</p><p><strong>Discussion and conclusions: </strong>Severe hypoglycemia is common in those with type 2 diabetes on insulin. Several insulin regimens were associated with severe hypoglycemia and/or all-cause mortality. However, additional research is required to determine whether this association is causal, or indicative of insulin regimen differences due to residual confounders such as diabetes severity, prognosis, or health literacy.</p>","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian journal of diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcjd.2025.05.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To compare severe hypoglycemia and all-cause mortality between insulin regimens in people with type 2 diabetes on insulin.
Methods: This retrospective cohort study included individuals with type 2 diabetes who received a first insulin prescription from Apr2007-Dec2018 in Manitoba, Canada. We used cox proportional hazard regression models to compare risks and time-to-events for severe hypoglycemia and all-cause mortality amongst insulin regimens, adjusting for covariates.
Results: 21,512 individuals were included with 1,156 (5.4%) individuals experiencing a severe hypoglycemic episode and 3,562 (16.6%) dying during the study period. When compared to long-acting insulin alone, short-acting, intermediate- plus short-acting, long- plus short-acting, and premixed insulins were associated with severe hypoglycemia. However, after removing individuals who had never been prescribed a non-insulin antihyperglycemic medication, short-acting was no longer associated with severe hypoglycemia with the adjusted HR going from 1.99(95% CI 1.44-2.74) for the entire cohort to 1.13(95% CI 0.63-2.04). When compared to long-acting insulin, short-acting insulin alone and premixed insulin were associated with a higher all-cause mortality in both the main analysis (adjusted HR 2.36[95% CI 2.06-2.72] and 1.17[95% CI 1.04-1.31], respectively) and the analysis which removed individuals who had never been prescribed a non-insulin antihyperglycemic agent.
Discussion and conclusions: Severe hypoglycemia is common in those with type 2 diabetes on insulin. Several insulin regimens were associated with severe hypoglycemia and/or all-cause mortality. However, additional research is required to determine whether this association is causal, or indicative of insulin regimen differences due to residual confounders such as diabetes severity, prognosis, or health literacy.
目的:比较使用胰岛素治疗的2型糖尿病患者的严重低血糖和全因死亡率。方法:这项回顾性队列研究包括2007年4月至2018年12月在加拿大马尼托巴省首次接受胰岛素处方的2型糖尿病患者。我们使用cox比例风险回归模型来比较胰岛素治疗方案中严重低血糖和全因死亡率的风险和时间,并对协变量进行调整。结果:21,512人被纳入研究,其中1,156人(5.4%)出现严重低血糖发作,3,562人(16.6%)在研究期间死亡。与单独使用长效胰岛素相比,短效胰岛素、中间加短效胰岛素、长效加短效胰岛素和预混胰岛素与严重低血糖有关。然而,在剔除从未开过非胰岛素降糖药物的个体后,短效降糖不再与严重低血糖相关,整个队列的调整后风险比从1.99(95% CI 1.44-2.74)上升到1.13(95% CI 0.63-2.04)。与长效胰岛素相比,单独使用短效胰岛素和预混胰岛素在主要分析(调整后的风险比分别为2.36[95% CI 2.06-2.72]和1.17[95% CI 1.04-1.31])和剔除从未使用过非胰岛素降糖药的个体的分析中均与更高的全因死亡率相关。讨论与结论:严重低血糖在使用胰岛素治疗的2型糖尿病患者中很常见。几种胰岛素治疗方案与严重低血糖和/或全因死亡率相关。然而,需要进一步的研究来确定这种关联是因果关系,还是表明由于糖尿病严重程度、预后或健康素养等残留混杂因素导致的胰岛素治疗方案差异。